| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.3 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |